SKP.L Regulatory News (SKP)

29 Jun 2007 13:27

Skyepharma PLC29 June 2007 SkyePharma PLC Announces Results of Shareholder Vote LONDON, UK, 29 June 2007 - SkyePharma PLC (LSE: SKP) announces the results ofthe voting by shareholders at the Annual General Meeting held earlier today.All resolutions were passed. Full details of the proxy voting will be available on our website(www.skyepharma.com) later today. For further information please contact: SkyePharma PLC Frank Condella +44 20 7491 1777 Ken Cunningham Peter Grant Financial Dynamics (UK Enquiries) David Yates +44 20 7831 3113 Deborah Scott Trout Group (US Enquiries) Christine Labaree +1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has eleven approved products in the areas of oral,inhalation and topical delivery. The Group's products are marketed throughoutthe world by leading pharmaceutical companies. For more information, visitwww.skyepharma.com This information is provided by RNS The company news service from the London Stock Exchange